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Meconium is fetal stool and its passage into the amniotic cavity will stain the 
amniotic fluid. The reported incidence of meconium stained liquor (MSL) among 
all deliveries varies between 7% and 22%. There is much controversy on 
whether the passage of meconium into the amniotic cavity is a physiological 
event or a pathological phenomenon representing fetal hypoxia. 
Isoprostanes are products of lipid peroxidation induced by free radicals within 
the cell membrane. 8-iso-prostaglandinF2a (8-iso-PGF2a), one of the 
isoprostanes, is a sensitive and specified marker of hypoxia-reoxygenation 
injuries and its measurement allows detection of such cellular damage before 
clinical manifestations appear. 
Amnioinfusion refers to the procedure of intrauterine saline infusion via the 
cervical route to dilute the intrauterine content of meconium and to release any 
cord compression due to reduced liquor volume. It is a common practice for 
pregnancies complicated with moderate or thick MSL in many obstetrics units. 
Objectives: 
1) To compare the umbilical cord plasma 8-iso-PGF2a levels between 
pregnancies complicated by moderate or thick MSL during labor and 
pregnancies with clear liquor; 
i 
2) To evaluate the effect of amnioinfusion on the umbilical cord plasma 8-iso-
PGF2a levels in pregnancies complicated by moderate or thick MSL. 
Results: 
Of the 276 pregnancies studied, 192 had clear liquor and 55 had moderate or 
thick MSL without amnioinfusion and 29 had moderate or thick MSL and 
received amnioinfusion. In the first part of this study, the total 8-iso PGF2a 
concentrations were significantly higher in those with moderate or thick MSL but 
did not receive amnioinfusion, compared to control cases with clear liquor 
[Median 719.2 pg/ml (interquartile range IQR: 448.1-935.0) \/s. 115.8 pg/ml (IQR: 
86.4-164.0), p< 0.001]. Using multiple regression analysis, moderate or thick 
MSL, duration of first stage of labour and intrapartum abnormal fetal heart 
tracing were independent factors on total 8-iso PGF2a concentrations in 
umbilical cord blood. In the second part of this study, the total 8-iso-PGF2a 
concentrations were significantly lower in those moderate or thick MSL 
pregnancies which received amnioinfusion (median 143.4 pg/ml; IQR 95.5 — 
370.4)， compared with those moderate or thick MSL cases without 
amnioinfusion (median 719.2 pg/ml; IQR: 448.1-935.0) (p<0.001). There was no 
significant difference in the total 8-iso-PGF2a concentrations between the control 




The umbilical cord plasma 8-iso prostaglandin F2a concentrations were 
significantly higher in pregnancies complicated by moderate or thick MSL 
compared to those with clear liquor. As the lipid peroxide levels in the fetal 
circulation reflect hypoxia-reoxygenation induced cellular damage within the fetal 
tissue, the result suggests some forms of hypoxia-reoxygenation injury exist in 
pregnancies complicated by moderate or thick MSL Moreover, the transcervical 
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INTRODUCTION 
CHAPTER 1 INTRODUCTION 
Meconium, fetal stool, passed into amniotic cavity and staining amniotic fluid is 
named meconium stained liquor (MSL). The reported incidence of MSL varied 
between 7-22% of all deliveries [1]. According to the obstetric audit of the Prince 
of Wales hospital, Hong Kong in the year 2001，the overall incidence of MSL 
was 18.7% and that of moderate or thick MSL was 10.7%. In the past, MSL was 
regarded as evidence of fetal compromise or distress, in particular, an 
association between moderate or thick MSL and increased neonatal mortality 
and morbidity was observed. However, a recent study observed sonographically 
that the fetus passed meconium under normal conditions [2]. This finding 
indicates that the passage of meconium might be a physiological event. In 
addition, most pregnancies with moderate or thick MSL appear to have normal 
neonatal outcomes. The association between meconium and fetal condition at 
birth is complex and puzzling. 
Amnioinfusion is a technique where normal saline is infused into the amniotic 
cavity. Over the last twenty years, amnioinfusion has been used in the Prince of 
Wales Hospital for pregnancies with moderate or thick MSL to dilute the 
concentration of meconium and to increase amniotic fluid volume. However, the 
evaluation of amnioinfusion effect for improving neonatal outcome in 
pregnancies complicated by MSL is inconsistent. 
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Most outcome parameters for assessment of neonatal condition are based on 
cord blood gas analysis and the Apgar scoring system, which reflect fetal 
metabolic adjustments and neurological state respectively. Other biological 
parameters such as erythropoietin, lactate and some metabolic products of 
nucleotide breakdown, i.e. hypoxanthine, xanthine and uridine, have been 
proposed as alternative measurements insteading hypoxia. 
Lipid peroxides are the by products of lipid peroxidation, which involves free 
radicals attacking phospholipids within cell membranes. Measurement of lipid 
peroxides in umbilical arterial blood plasma can reflect fetal cellular injury by free 
radicals [3]. Isoprostanes, also products of lipid peroxidation, will be used in this 
thesis to explore fetal cellular damage by free radicals in pregnancies 
complicated by moderate or thick MSL; and to evaluate the effect of 
amnioinfusion for moderate or thick MSL. 
2 
© y A T E [1 
1 
MECONIUM STAINED LIQUOR 
CHAPTER 2 MECONIUM STAINED LIQUOR 
2.1 AMNIOTIC FLUID 
2.1.1 Function of Amniotic Fluid 
The fluid enclosed by the amniotic sac and surrounding the fetus is named 
amniotic fluid. This fluid provides several important benefits to the fetus in that it 
cushions the fetus against trauma, has antibacterial properties to lessen 
infections, and functions as a reservoir that may provide a short-term source of 
fluid and nutrients to the fetus. Normal amounts of amniotic fluid are required for 
the proper development of fetal musculoskeletal [4]，gastrointestinal [5] and 
respiratory [6-8] systems. 
2.1.2 Composition Of Amniotic Fluid 
The major solutes in amniotic fluid are sodium, chloride, potassium, urea, 
bicarbonate, and lactate. In the first trimester, the sodium and chloride 
concentrations of the amniotic fluid are similar to fetal plasma. In the last two 
trimesters, the majority of these solutes enter the amniotic fluid via the fetal urine, 
which is hypotonic compared to fetal plasma. Thus, amniotic sodium and 
chloride ion concentrations decrease relative to fetal plasma concentrations, in 
parallel with the decrease in amniotic osmolarity [9-12]. 
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2.1.3 Regulation Of Amniotic Fluid 
Amniotic fluid is a dynamic reservoir with large daily flows in and out of the 
amniotic cavity. Current evidence indicates that significant exchanges of water 
and solute take place between amniotic fluid and fetus near term by several 
pathways: 1) fetal swallowing，2) fetal urination, and 3) within the fetal 
respiratory tract where the alveolar capillary bed is perfused by amniotic fluid 
transported in and out by respiratory movements. Under certain conditions, 
transfer of water and solute probably also occurs across the chorionic plate 
between the fetal circulation and amniotic fluid. The large fetal skin capillary bed 
may serve as a site for amniotic water and solute exchange in early pregnancy 
before keratinisation of fetal skin occures at about 24 to 26 weeks' gestational 
age. The major pathway for intrauterine water accumulation in pregnancy is 
across the chorion frondosum between the maternal and fetal compartments. 
This net water transfer occurs from the mother in response to very small 
intermittent chemical potential gradients [13]. 
2.1.4 Abnormality Of Amniotic Fluid Volume 
Amniotic fluid volumes are rarely measured because of methodological 
limitations. The best estimate can be obtained by ultrasound assessment. Semi-
quantitative ultrasonographic indices of amniotic fluid volume are routinely 
determined, with the 4-quadrant amniotic fluid index (AFI) being the most widely 
used. AFI of 24cm or more is defined as polyhydramnios [14]. An AFI of 5cm or 
less is defined as oligohydramnios [15，16]. 
4 
Oligohydramnios or polyhydramnios occur in about 1 %-7% of all pregnancies 
and are both associated with adverse perinatal outcomes [17]. Pauer et al 
observed that, 48% of the fetuses with polyhydramnios had severe 
malformations, which was significantly higher than the rate of 11.8% of fetal 
malformations presenting with oligohydramnios [17]. Oligohydramnios is related 
to malformation of the urinary tract, whereas polyhydramnios is associated with 
anomalies of the gastrointestinal tract [17], neural tube defects and fetal hydrops 
18, 19]. Prolonged oligohydramnios may induce malformation in various 
systems, including lung hypoplasia [20], limb contraction [4] and even fetal 
spinal flexion [21]. 
Normal amniotic fluid volume not only provides an expended space for fetal 
development normally, but also protects the umbilical cord from the pressure of 
uterine contraction, especially during labour period. In cases of oligohydramnios, 
the protective cushion of amniotic fluid is lost, and cord compression may occur, 
leading to fetal hypoxia. In an early study or post term pregnancy, close to 8% of 
pregnancies with oligohydramnios were delivered by caesarean section for fetal 
distress [22]. Cord compression may have played a key role in the 
pathophysiology of fetal distress in these pregnancies. It has been shown that a 
raised lipid peroxide level is a sensitive marker of fetal hypoxia [23]. Rogers et 
al demonstrated that cord blood lipid peroxide levels increase in 
oligohydramnios [24]，but can be significantly lowered if amnioinfusion is applied 
for treating oligohydramnios [25]. 
5 
Placental insufficiency is widely accepted as one of the causes of 
oligohydramnios. An experimental study on fetal sheep demonstrated that fetal 
urine production and glomerular filtration rate were significantly lower in fetuses, 
following umbilicoplacental embolization, when compared to those in a control 
group [26]. Chronic placental insufficiency is associated with alteration of 
amniotic fluid composition and subsequent to excessive absorption of amniotic 
fluid water into the fetal circulation [27]. Placental insufficiency also reduces fetal 
lung blood flow subsequently decreasing lung fluid production and finally 
resulting in oligohydramnios [28]. 
2.2 MECONIUM STAINED LIQUOR 
2.2.1 Formation And Composition Of Meconium 
Meconium is fetal stool. Its presence in the fetal gut may occur as early as 70-85 
days of gestation. Meconium consists of material accumulated by swallowing 
amniotic fluid and secretions from the lungs and gastrointestinal tract. It is 
blackish-green, odourless, viscid, sticky, and has a pH ranging between 5.5-7.0. 
The composition of term fetal meconium includes: water, mucopolysaccharides, 
cholesterol and sterol precursors, protein, lipid, bile acids and salts, enzymes, 
blood group substances, squamous cells and vernix caseosa. Meconium is 
sterile, but when it is excreted into amniotic fluid, it becomes an excellent culture 
medium for bacteria [29]. 
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2.2.2 Peristalsis Of Fetal Gastrointestinal Tract 
Peristalsis in the fetal bowel is detectable after the formation of muscle layers 
and circular folds of the gastrointestinal tract around the week of gestation. 
However, motility of both the large and small bowels appears to be poorly 
developed and coordinated until the fetus has reached the week of 
gestation [30]. The rate of peristalsis increases with advancing gestational age. 
This mechanism may provide substantial support for the maturation theory of 
meconium passage (see below). 
2.2.3 Meconium Stained Liquor (MSL) 
MSL is fetal stool passed into amniotic cavity and staining amniotic fluid, with a 
reported incidence varying between 7 and 22% [1] . It has been a long-standing 
controversy as whether the in-utero passage of meconium into the amniotic 
cavity represents a fetal response to hypoxia or merely a physiological event 
related to fetal maturity. In a review of 9,542 singleton pregnancies, the 
incidence of MSL increased progressively from 6% in preterm gestation to 
29.5% at 41 weeks of gestation [31]. There are currently three major theories 
regarding the passage of meconium. 
2.2.3.1 Maturation Theory 
Meconium is seldom passed by preterm fetuses and meconium passage occurs 
increasingly drematly increasing with gestational age [31]. Defecation of 
meconium into amniotic cavity may therefore only reflect gestational maturity. In 
an early experimental study [32], dye was injected into the amniotic cavity of 
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pregnant guinea pigs in mid-gestation and was observed by sequential x-ray 
examination. The study showed that healthy fetuses pass dye medium more 
frequently at term than those at early gestational age. In 1963，McLain also 
discovered that the transit time to the fetal colon is 9 hours in fetus at 32-weeks 
and it is shortened to 4.5 hours in term fetuses [33]. Moreover, many clinical 
studies have shown that meconium passage is rare before 38 weeks but can be 
found in over 30% of pregnancies of more than 42 weeks gestation [1]. These 
studies provide strong evidence that passage of meconium is associated with 
fetal maturity. This is also supported by the findings that majority of MSL 
pregnancies had good neonatal outcomes [34-36]. 
However, the association of more frequent MSL and advanced gestational age 
does not automatically exclude other causes apart from physiological maturation 
as the reason for in-utero passage of meconium. In prolonged pregnancy, 
placental function progressively decreases, with increasing risk of intrauterine 
fetal distress [37]. Ultrasound observational studies that have shown resistance 
in the fetoplacental circulation is significantly increased with advancing 
gestational age in normal pregnancy [38]. Chronic fetal hypoxia or 
oligohydramnios, which result from placental insufficiency, may stimulate fetal 
passage of meconium. Kariniemi et al have reported the percentage of calcified 
placenta in 40.6% of the meconium group compared to only 26.8% in non-
meconium group [39]，The placental weight was significantly lower in the 
meconium group compared to the non-meconium group, while the meconium 
group had more advanced gestational age. There were lower umbilical artery pH 
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value and base excess in the meconium group than in the control group [39]. 
These findings further suggest that passage of meconium in late gestational age 
might sometimes be due to chronic intrauterine fetal stress secondary to 
placental insufficiency, instead of only a physiological event. 
2.2.3.2 Cord Compression Theory 
Bowel activity is primarily controlled by local reflexes acting through intramural 
neural plexuses. Parasympathetic activity increases motor activity in the rectum 
while inhibiting the constriction of internal anal sphincter. The symphpathetic 
system acts the opposite to it. Hon [40] suggested that passage of meconium by 
the fetus was the result of vagal stimulation by cord compression. In his study, it 
was demonstrated that meconium stained liquor was associated with fetal 
electrocardiographic (ECG) pattens of "bradycardia", "sinus arrest" and "nodal 
rhythem", which had been shown to be typical for umbilical cord compression. 
These fetal ECG patterns changed with acceleration in the baseline fetal heart 
rate and disappearance of premature nodal contractions after the maternal 
administration of atropine [40]. This hypothesis is in line with the study reported 
by Sheiner et al that thick MSL was significantly associated with 
oligohydramnios, which predisposed to cord compression and abnormal fetal 
heart tracing during first or second stage or labour [41]. However, 
oligohydramnios may also be a pathological event related to fetal hypoxia. It is 
unknown whether passage of meconium is the result of fetal hypoxia or only a 
physiological neurological reaction resulting from cord compression. On the 
other hand, some studies have reported that MSL is infrequently related to 
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oligohydramnios [42，43] or abnormal fetal heart rate patterns [34，44]. These 
findings do not provide support for the cord compression theory. 
2.2.3.3 Fetal Hypoxia Theory 
The relationship between fetal hypoxia, intestinal hyperperistalsis，and relaxation 
of the anal sphincter has been studied for many years. In 1954, Walker 
demonstrated that meconium was released more commonly when the oxygen 
saturation of the umbilical vein was below 30 percent [45]. In a small study of 
three animals, meconium was observed in amniotic fluid after 30 minutes partial 
umbilical cord occlusion resulting in hypoxia and acidosis [46]. Massive 
meconium release prior to fetal demise was noted after injection of sodium 
pentobarbital, probably related to terminal hypotension and loss of tone in the 
fetus [47]. These findings indicate fetuses with passage of meconium may have 
suffered from varying degrees of intrauterine distress. In contrast, another 
animal study reported that goat fetuses can defecate x-ray contrast medium into 
amniotic fluid under normoxic conditions [48]. Ciftici also demonstrated that fetal 
hypoxia does not increase fetal peristalsis. In this experimental study, 
radioactive medium was injected into the gluteus muscle of pregnant rabbit 
fetuses either under artificial uteroplacental ischemia or under normal conditions. 
Fetal hypoxia was confirmed by fetal blood gas analysis. A gamma counter 
determined the radioactivity of each sample. It showed that intestinal transport 
time was similar in the fetal hypoxia and non-hypoxia groups. In addition, the 
authors noted that radioactive medium accumulated in the amniotic cavity and 
that the diffusion rate into the maternal blood was lower in the fetal hypoxia 
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group compared with the non-hypoxia group [49]. This study suggests that fetal 
hypoxia is not associated with meconium passage from the gut, but a decreased 
clearance from the amniotic fluid results in accumulation of meconium content. 
2.2.4 Fetal Effect Of Meconium In Amniotic Cavity 
It is known that meconium can diffuse into placental and umbilical cord tissue 
and cause vasoconstriction [50-52]. Miller discovered 8 of 11 placentae exposed 
to various meconium solutions had meconium pigment laden macrophages in 
the amnion after 1 hour and all samples showed chorionic pigmented 
macrophages after 3 hours [53]. In 1989, Altshuler at al discovered that 
exposure of tissure to meconium maximally produced 62.9% of serotonin-
induced vasocontraction [51]. Similarly, in another in vitro study, meconium 
solution at different concentrations was injected into isolated placental vessels, 
and then the infusion pressure of placental vasculature was measured. It was 
demonstrated that bolus injections of MSL into the fetal circulation resulted in a 
concentration-dependent increase in perfusion pressure, and high 
concentrations of MSL induced longer vasoconstriction low concentrations of 
MSL [54]. Meconium stimulates constriction of the umbilical vein, which may 
result in cord vascular necrosis, thereby increasing the likelihood of fetal 
hypoxemia [52，55]. Vasoconstriction affecting fetal-placenta丨 blood flow and 
leading to hypoperfusion may directly contribute to the occurrence of an adverse 
pregnancy outcome. 
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2.2.5 Meconium Aspiration Syndrome 
Intrauterine aspiration can be observed from the 11th-12th week of pregnancy 
[39] by microscopical examination of the bronchi and alveolar ducts. The 
aspiration of cells from the amnion and epidermis is not harmful to the fetus [39]. 
However, when meconium is aspirated into lung, it acts as a toxic substance 
causing chemical pneumonitis and pneumonia [56, 57]. Meconium has high 
phospholipase A2 activity and induces cellular injury and apoptosis in 
experimental lung [58]. Kearney observed three neonates with chronic 
meconium aspiration who had distinctive subpleural plate-infarcts of the lungs 
caused by meconium-induced vasoconstriction of peripheral preacinar arteries, 
followed by lung rupture and meconium embolism [59]. A recent study showed 
that meconium was an activator of complement, which might play an important 
role in the pathogenesis of meconium aspiration syndrome [60: • 
Meconium aspiration syndrome is reported to occur in approximately 5% to 25% 
of neonates delivered through MSL and severe disease requiring mechanical 
ventilation occurs in as many as 30% of cases [61]. James and Lawrence 
clarified the various degrees of meconium aspiration syndrome into mild and 
severe categories. In the mild form, the disease may present with neonatal 
tachypnoea, associated with normal pH and lowered PC〇2, which can resolve 
within 2 to 3 days after birth. The severe form of the syndrome can present as 
hypoxemia, acidosis, and respiratory failure within a few hours after birth [62]. 
Meconium aspiration syndrome is the main reason for increased neonatal 
mortality and sequelae in pregnancies complicated by MSL [63，64, 65]. 
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2.2.6 Clinical Significance And Limitation Of Studies 
In the third trimester, the incidence of meconium passage increases. The use of 
amnioscopy for spectory the quality of amniotic fluid provides a useful method to 
detect MSL before rupture of the amniotic membrane during the antepartum 
period. Saldana et al [66] used amnioscopy to examine 508 pregnancies and 
found that the incidence of antepartum MSL was 2.2% while intrapartum MSL 
was found in 15% of cases. A significant incidence of depressed neonates was 
found in the latter group. Antenatal ultrasound scanning is another method for 
observing fetal condition. In 240 cases diagnosis by sonography, Ramon y Cajal 
et al noted fetal defecation occurs under normal conditions and suggested that 
defecation in utero is a physiological behavior[2]. Antepartum MSL by itself, was 
not associated with low Apgar scores or fetal acidosis at delivery [2，66]. Allen et 
al reported 79 cases where meconium was discovered by amniocentesis in the 
mid-trimester and most of them had clear liquor at the time of delivery. These 
findings may imply passage of meconium during antenatal period is a 
physiological event [48] and meconium is regularly cleared from amniotic fluid 
[49]. 
Regarding the significance of intrapartum passage of meconium, Gejrot first 
reported that passage of meconium during active labour was more likely to lead 
to fetal asphyxia at birth when compared to cases with meconium discovered at 
the time of rupture of membranes in early labour [67]. In comparison to 
pregnancies with clear liquor, there was a significantly higher proportion of 
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abnormal cardiotocography (CTG) in women with MSL at matched gestational 
age, suggesting that MSL is more than just a physiological event [68]. These 
findings imply intrapartum passage of meconium is related to fetal hypoxia. 
Despite all these findings, most pregnancies with moderate or thick MSL have 
good neonatal outcomes [66]. In addition, pregnancies with MSL were shown to 
have similar outcomes based on the 5-minute Apgar score or the umbilical 
arterial PH when compared to those with dear liquor after controlling for the 
confounding factor of abnormal CTG tracings [34，35]. It is there is no fetal 
distress, the presence or absence of meconium has no gross impact on 
neonatal outcome. It has also been demonstrated that poor neonatal outcomes 
are mainly associated with fetal acidemia together with MSL rather than MSL 
alone [36]. The latter finding suggests that MSL represents merely an 
environmental hazard to the fetus rather than a marker of fetal hypoxia. To 
understand the significance of intrapartum MSL, further research should be 
considered. 
2.3 Purpose Of Study 
Although parameters such as Apgar scores and acid base status of umbilical 
cord blood are commonly used for assessment of perinatal outcome, they are 
both limited by their poor correlation with subsequent neurodevelopmental 
handicap [69]. 
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Oxidative stress and the resulting oxygen free radicals generated have been 
implicated in the pathogenesis of perinatal brain injury [70]. Recent work showed 
that the products of free radical-mediated lipid peroxidation, which are surrogate 
markers of oxidative stress, are elevated in fetal circulation in response to 
intrapartum hypoxia [3，24，71-75]. Their measurement in the umbilical cord 
artery is proposed to be a better marker of fetal hypoxia compared to Apgar 
score or acid base status [3，76]. 
One of the products of lipid peroxidation, 8-iso-prostaglandin F2a. is specific to 
oxidative stress [77]. Qin et al demostrated satisfactory precision in its 
measurement in umbilical cord blood and higher levels were seen in the 
presence of suspected fetal distress or tight nuchal cord entry level [78，79]. The 
aim of the first part of this research was to study the concentrations of 8-iso-
prostaglandin f2a in umbilical cord arterial blood from pregnancies complicated 
by moderate or thick MSL, and to compare this to patients with clear amniotic 
fluid. 
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OXIDATIVE STRESS AND FETAL HYPOXIA 
CHAPTER 3 OXIDATIVE STRESS AND FETAL HYPOXIA 
3.1 OXIDATIVE STRESS 
Oxygen molecules represent 20% of air, and act as terminal oxidants during 
respiration, which is the main source of energy in aerobic organisms. During 
normal aerobic metabolism, cells have intact pro-oxidant/anti-oxidant systems 
that continuously generate and detoxify oxidants. Oxidative stress results from 
the metabolic reactions that use oxygen under pathological conditions，and it is 
defined as a disturbance in the equilibrium status between pro-oxidant and anti-
oxidant systems in intact cells. Under hypoxic conditions, for example, the lack 
of oxygen leads to cellular anaerobic metabolism, and the pro-oxidant systems 
outbalance the anti-oxidant, potentially inducing oxidative damage in lipids, 
proteins, carbohydrates, and nucleic acids. When pro-oxidant metabolism, 
predominates the reactive oxidants accumulate and play an important role in the 
pathogenesis of many common diseases in mankind. 
3.2 FREE RADICALS 
A free radical is any molecule containing a single, unpaired electron. Free 
radicals are highly reactive and transient. Free radicals are generated in vivo as 
byproducts of normal metabolism and they are also produced when an organism 
is exposed to ionizing radiation, to drugs capable of redox cycling, or to 
xenobiotics that can form free radical metabolites in situ. Due to its highly 
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reactive characteristics, free radical induced cellular damage occurs when 
proxidant and antioxidant systems are unbalanced. 
3.2.1 Sources Of Free Radicals 
There are two main sources of free radicals: biological sources and intracellular 
sources. 
3.2.1.1 Biological Source Of Free Radicals 
The variable biological sources or initiators of free radicals include antibiotics [80， 
81], phagocytic cells [82, 83], radiation [84] and xenobiotics [85-88]. Free radical 
reactions are critical for the normal operation of a wide spectrum of biological 
processes. Free radicals, as intermediates for immunological defense, are 
yielded by electron transportation during many cellular enzymes' catalytic 
metabolism. As result of the existance of oxygen molecules in aerobic 
organisms and its acceptability of electrons, oxygen-centered free radicals act 
frequently as mediators of cellular free radical formation. 
3.2.1.2 Intracellular Sources Of Free Radicals 
Intracellular sources of free radicals comprises of autoxidation of small 
molecules, soluble enzymes and proteins in plasma membranes, mitochondrial 
electron transport, peroxisomes, endoplasmic reticulum and nuclear membrane 
electron transport. Among the variety of sources, xanthine oxidase, one of the 
soluble enzymes, is associated with increasing free radical production following 
reduction of oxygen supply in vivo. Proteolytic modification of xanthine oxidase 
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during ischemia in vivo converts the enzyme from the dehydrogenase form to 
the oxidase form [89, 90]. The relative proportion of 02 ' and H2O2 released from 
the active site of xanthine oxidase depends on pH, oxygen concentrations, and 
substrate concentrations [91]. When reoxygenation occurs after ischemia, free 
oxygen radicals are generated. 
Free radical production in mitochondria could be influenced by the availability of 
endogenous factors such as NAD-linked substrates, succinate, ADP and oxygen. 
If oxygen is present in concentrations that limit mitochondrial reduction to H2O 
by cytochrome oxidase, increased respiratory chain reduction and an 
accumulation of reduced cofactors in cells may enhance CV production by 
electron transport components in ischemic cell [92]. 
3.2.1.3 Composition Of Free Radicals And Reactive Oxygen Species 
Radicals of oxygen (superoxide radicals, hydroxy! radicals, and peroxy radicals), 
reactive non-radical oxygen species such as hydrogen peroxide and singlet 
oxygen, as well as carbon, nitrogen, and sulfur radicals comprise the variety of 
reactive molecules that constitute oxidative stress. 
Superoxide radical (O2 -) is generated continuously by several cellular processes 
including the microsomal and mitochondria electron transport systems. In 
addition, xanthine dehydrogenase/oxidase and other cellular oxidases are 
important sources of this molecule. Cellular immunological systems contain the 
NADPH oxidase, which is a membrane - bound enzyme complex that reduces 
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oxygen with NADPH to produce copious amounts of superoxide radicals. The 
products play an essential role for effective killing of bacteria. 
Superoxide radical is not a particularly reactive molecule and only can diffuse a 
short distance from its site of production, but it may combine with other reactive 
species such as nitric oxide to yield the more reactive molecule, peroxynitrite. 
Much of the superoxide radical generated is converted into hydrogen peroxide 
by superoxide dismutase, which is a very important enzyme which functions as 
a cellular anti-oxidant. 
Hydrogen peroxide (H2O2), unlike the other oxygen free radicals, is a non-
radical molecule (paired electrons) generated by the same source that produce 
superoxide radical since two superoxide radicals can readily dismute to 
hydrogen peroxide and oxygen. Hydrogen peroxide has the capability to diffuse 
over considerable distances and pass through cell membranes. Hydrogen 
peroxide and superoxide radicals can be generated both inside and outside the 
cell. 
Hydroxy! radical (HO.) is considered to be the most toxic of the partially reduced 
oxygen species, since it is very reactive with all kinds of biological 
macromolecules, producing products that cannot be regenerated by cellular 
metabolic processes. The reaction rate of hydroxy I radical is diffusion-controlled 
and it reacts closely to its site of production. Therefore, damage by this radical is 
very site-specific. 
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3.2.2 Cellular Components At Risk From Free Radicals Damage 
Free radicals are highly reactive molecules with one or more unpaired electrons. 
They can react with DNA, proteins and lipids causing varying degrees damage 
and cellular dysfunction. Oxygen free radicals are normal products of 
mitochondrial oxidative metabolism. It is estimated that 2% to 3% of oxygen 
consumption is diverted to production of oxygen free radicals [93]. Damage from 
free radicals is normally prevented by endogenous antioxidant systems. After 
ischemia and reperfusion, however, free radical production overwhelms the 
endogenous protective mechanisms, resulting in damage to DNA, proteins, and 
lipids. 
3.2.2.1 Proteins 
Proteins containing the amino acids tryptophan, tyrosine, phenylalanine, 
histidine, methionine and cysteine can be modified by free radicals [94]. 
Aggressive molecular such as hydroxyl radical can fragment proteins with 
specific amino acids such as proline by reactory at the specific amnio acid site. 
The result is a break in the polypeptide chain. Metal binding sites of proteins are 
especially susceptible to oxidative events through interaction with the metal ions. 
These reactions usually produce irreversible modifications to amino acids. The 
modifications may produce signal sequences that are recognized by specific 
cellular proteases in degradation. 
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3.2.2.2 Nucleic Acids And DNA 
Cytotoxicity in large part is a consequence of chromosomal aberrations arising 
from either nucleric acid base modifications or DNA strand scission [95]. Cell 
death and mutations may arise from free radicals generated during normal 
metabolism, hyperoxia, and environmental pollutants. Superoxide radical (O2-) 
and hydrogen peroxide (H2O2) can interact by a metal-catalyzed process to 
generate OH", which attack the sugarphosphate backbone within DNA, resulting 
in strand scission [92]. 
3.2.2.3 Membrane Lipids 
The plasma membrane is a critical site of free radical reactions. The unsaturated 
bonds of membrane cholestrol and fatty acids can readily react with free radicals 
and undergo peroxidation. The process of lipid peroxidation can become 
autocatalytic after initiation and will yield lipid peroxide, lipid alcohol, and 
aldehydic by-products. Lipid peroxidation induced cell damage has been 
extensively studied and lipid peroxides, which are the products of lipid 
peroxidation, become excellent markers of cell damage. 
3.2.3 Lipid Peroxidation 
3.2.3.1 Chemical Substances Of Membranes 
Lipid fluidity offers several properties on membranes, which are essential to the 
proper functioning of the cell. A fluid membrane is necessary for the efficient 
diffusion of water, the operation of membrane-associated proteins (receptors, 
transporters, enzymes), and membrane budding and fusion [96]. 
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This fluidity is maintained by polyunsaturated fatty acid (PUFA). All PUFA share 
a common backbone structure of membranes. The adjacent double bond 
weakens the carbon-allylic hydrogen bonds. These allylic hydrogens are partially 
activated towards abstraction by free radicals. The lipid radical formed will then 
react with oxygen molecule in the subsequent chain of reactions resulting in the 
breakdown of PUFA structure. This reaction is named as lipid peroxidation [96]. 
3.2.3.2 The Reactions Of Lipid Peroxidation 
The reactions of lipid peroxidation are summarized in the following categories in 
Morton's review: initiation, propagation, and termination [96]: 
1) Initiation is the reaction of the PUFA side chain with a reactive free radical 
to form a lipid radical, which then reacts with oxygen molecule to form a peroxy 
lipid radical. 
2) Propagation is the reaction of a peroxy lipid radical with another PUFA 
side chain to yield a lipid hydroperoxide and new lipid radical, thus conserving 
the number of radicals in the reaction sequence. 
3) Termination is the removal of free radicals, by combining two radicals 
combine to yield a non-radical product, thus the chain reaction ended. 
Besides free radicals, ion salts such as iron and copper are required for the 
initiation of the lipid peroxidation process. 
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3.2.3.3 Lipid Peroxidation In Pregnancy 
Serum lipid peroxide concentrations in pregnant subjects are significantly higher 
than those in non-pregnant subjects and the concentrations of lipid peroxides 
progressively increase with advancing gestation [97-99]. The elevation of the 
lipid peroxide levels in normal pregnant subjects is due to metabolism changes 
in all of the fractions of serum lipoproteins. Walsh demonstrated more lipid 
peroxides are secreted into the maternal circulation by the placenta than into the 
fetal circulation, and suggested that placental tissue might be a major source of 
lipid peroxidation products in maternal blood [100]. 
Serum levels of lipid peroxides remain relatively stable throughout gestation, but 
the levels of vitamin E progressively increase. Similarly, plasma levels of 
prostacyclin progressively increase with advancing gestation, whereas levels of 
thromboxane progressively decreased. The change in the ratios of 
prostacyclin/thromboxane and vitamin E/lipid peroxides suggests that the 
vasodilating actions of prostacyclin and the antioxidant activity of vitamin E are 
progressively favored with advancing gestation in the normal pregnant women 
[99]. 
In pathophysiological situations, however, excesive lipid peroxidation may be 
involved in endothelial cell injury, placental vasoconstriction, visceral 
vasorelaxation and imbalance between thromboxane and prostacyclin that are 
associated with pre-eclampsia and severe intrauterine growth retardation. 
23 
3.2.4 Protection Against Lipid Peroxidation 
To counter the attacks by free radicals, there are several systematic defence 
mechanisms. Under normal conditions，these defences appear to provide 
adequate protection for the cell membranes, but the possibility exists that in 
certain circumstances, such as hypoxia-reoxygenation, cancers or Alzheimer's 
disease, the effectiveness of these defences may decreased or even completely 
overwhelmed. 
The antioxidant enzymes superoxide dismutase, catalase, and glutathione 
peroxidase act as the first line of defence to intercept the reactive oxygen 
species directly. If these defences are overwhelmed and progress to lipid 
peroxidation, a second line of defence comes into play. Phospholipid 
hydroperoxide glutathione peroxidase acts to eliminate peroxidized membrane 
components by reducing peroxides to alcohols. This action prevents the 
initiation of new chain reactions by ferrous ions. The antioxidant vitamins E and 
C also collaborate to terminate chain reactions and stop further accumulation of 
free-radical-induced lipid peroxides. When all these defences are either 
overwhelmed or consumed, cell membranes become damaged and 
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Isoprostanes are a new class of lipid peroxidation products, isomers of the 
conventional enzymatically derived prostaglandin, which are produced in vivo 
primarily by a free radical-mediated non-enzymatic catalyzed peroxidation of 
polyunsaturated fatty acids [102]. 
3.2.5.2 Formation Of Isoprostanes 
The mechanism of formation of the F2 isoprostanes (F2-IS0PS) is analogous to 
the generation of bicycloendoperoxide intermediates resulting from the 
peroxidation of polyunsaturated fatty acid (PUFA) [103]. 
The precursor arachidonic acid initially undergoes abstraction of an allylic 
hydrogen atom to yield an arachidonyl radical. Subsequently, there is insertion 
of oxygen to yield peroxyl radicals. Depending on the site of hydrogen 
abstraction and oxygen insertion, 4 different peroxyl radical isomers are formed. 
Endocyclization of the radicals then occurs, followed by the addition of another 
molecule of oxygen to yield 4 bicycloendoperoxide (PGG2-like) regioisomers. 
These intermediates are then reduced to F2-IS0PS. Each of the 4 regioisomers 
can theoretically comprise of 8 racemic diastereomers. Thus, a total of 64 
different compounds can be generated [104]. 
Several structural aspects of the F2-IS0PS are noteworthy in comparison with 
cyclooxygenase derived PGs. The pathway of formation of the F2-IS0PS leads to 
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the formation of 4 regioisomers (l-IV). Compounds comprising regioisomers I 
and IV predominate owing to the fact that regioisomers II and III derive from the 
same arachidonyl radical precursor [105]. According to the location of the side 
chain hydroxy I group, 4 classes (l-IV) of F2-IS0PS： regioisomer I is a 5-F2-IS0P, II 
is a 8-F2-IS0P, III is a 12 F2-IS0P, and IV is a I5-F2-IS0P. 8-iso-prostaglandin 
F2aipha (8-iso-PGF2a Of 15-F2rlsoP) is extensively studied among the 
regioisomers. The chemical structure of 8-iso-PGF2a is shown in Figure 3.2. 
Trivial amounts of this compound are formed via the cyclooxygenase, wheras 
free radical mediated non-enzymatic oxidation of arachidonic acid accounts for 
virtually all of the formation of the compound in vivo [106]. 8-iso-PGF2a is one of 
the most abundant F2-IS0PS that is produced in vivo [107]. 
3.2.5.3 Metabolism Of Isoprostanes 
The t clearance of 8-iso-PGF2a from the circulation is about 16 minutes [108]. 
The lung is a major site of metabolic clearance of F2-IS0PS from the circulation 
[108，109]. The prostaglandin transporter (PGT), which is expressed in high 
level in the lung of rats [110], transported 8-iso-PGE2 and 8-iso-PGF2 [111]. 
These observations suggest that the isoprostanes are rapidly taken up and 
metabolized by tissues in a manner similar to the cyclooxygenase derived 
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Figure 3.2 Chemical structure of 8-iso-PGF2a 
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3.2.5.4 Biological Characteristics Of Isoprostanes 
Isoprostanes are a family of compounds of polyunsaturated fatty acid produced 
via a free-radical-catalyzed mechanism. Fa-isoprostanes are prostaglandin F20 
isomers derived from arachidonic acid in polyunsaturated fatty acids. These 
compounds induce potent vasoconstriction, platelet aggregation [112, 113] and 
cell proliferation. Direct or indirect vasoconstrictor actions of isoprostanes 
contribute to the pathogenesis of pre-eclampsia as higher concentrations of 
isoprostanes are formed in maternal plasma from pre-eclamptic women 
comparied with normotensive pregnant women [114-116]. With increased 
isoprostanes found in cerebral tissue after brain injury, isoprostanes were 
proposed as a strong vasoconstrictor responsible for reducing cerebral blood 
flow [117，118]. The vascular effect of isoprostanes or heart [119, 120] and lung 
[121，122] resulting from ischemia-reperfusion has been observed both in 
experimental and clinical studies. 
3.2.5.5 Isoprostanes As Mediators Of Oxidantive Stress 
As products of free radical induced lipid peroxidation, isoprostanes have been 
proposed as reliable markers of oxidative stress in vivo [107，123-125] since 
Morrow used GC-MS as measurement to determine the concentration of 
isoprostanes in biological fluids and related their increase to many pathological 
diseases [77]. 
The application of isoprostanes as markers of oxidative stress in the obstetric 
field is widely accepted. Pregnancy complications that have been extensively 
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studied include: pregnancy-induced hypertension [114，115, 126], diabetes 
mellitus [127, 128], and other obstetric complications associated with fetal 
hypoxia. 
Increase of the concentration of 8-iso-PGF2a in umbilical arterial blood plasma 
has been demonstrated in association with intrapartum hypoxic complications 
such as fetal distress and tight nuchal cord [79]. Intrauterine growth retardation, 
which is related to placental insufficiency, is also associated with increased 8-
iso-PG F2a in maternal serum [129]. 
Isoprostanes provide a sensitive marker of oxidative stress allow exploration of 
oxidative cellular injury in pathologic pregnances. 
3.3 FETAL HYPOXIA 
3.3.1 Fetal Metabolism And Energy Supply 
The fetus has two distinct uses for maternally supplied nutrients: (1) as a source 
of oxidizable fuel to meet ongoing energy requirements for survival; and (2) as a 
source of carbon and nitrogen building blocks to achieve rapid fetal growth. 
Under normal conditions, aerobic metabolism occurs with sufficient oxygen 
supply to the fetus. Large amounts of energy, in the form of adenosine 
triphosphate (ATP), are produced, together with carbon dioxide (C〇2) and water 
(H2O) as end products, which are easily removed from the fetal circulation 
through the placenta. If the oxygen supply is unsufficient, then the fetal tissues 
will switch to anaerobic metabolism. Here the end products are hydrogen ions 
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(H+) and lactate [130]. These metabolites are also cleared from the fetal 
circulation through the placenta but at a much slower rate than CO2 and H2O 
[131]. Anaerobic metabolism produces less energy (2 ATP for each glucose 
molecule) compared to aerobic conditions (36 ATP for each glucose molecule). 
The principal energy source within the cell is the formation of energy-rich 
phosphorous compounds, i.e., ATP. Nicotinamide adenine dinucleotide (NAD+) 
is a powerful hydrogen acceptor. With aerobic metabolism in the citric acid cycle, 
NAD+ accepts a hydrogen ion to produce reduced NAD, i.e., NADH. Along with 
the catabolic reaction of NADH, oxygen is directly consumed (NADH + H+ + 1/2 
O2 -> NAD+ + H2O). This reaction occurs at the inner membrane of the 
mitochondrion with release of large amounts of energy to drive the conversion: 
ADP + Pi ^ ATP + H2O: so-called oxidative phosphorylation [132]. (Figure 3.3) 
With sufficient oxygen supply, the cell maintains oxidative metabolism and there 
is a steady state between lactate and pyruvate concentrations (L/P ratio). With 
anaerobic metabolism, the L/P ratio increases. NAD+ is consumed during 
glycolysis in cytosol and in the citric acid cycle within the mitochondrion and 
reduced to NADH. As cellular metabolism continues, it is crucial to generate 
NAD+. This could be done within the mitochondrion in a process that requires 
oxygen. Under the shortage of oxygen, less NAD+ is generated; less energy 
released to form ATP and subsequently to increased L/P ratio. NAD+ is 
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Figure 3.3 Production of reactive oxygen metabolites by free radicals during 
reperfusion [132] 
32 
Many cellular functions rely on ion gradients across cell membranes. Ion pumps 
require ATP to function. With depletion of cellular energy, these functions cannot 
be continued as regeneration of ATP stops. Hypoxia leads to catabolism of ATP, 
through adenosine di- (ADP) and mono- (AMP) phosphate, to hypoxanthine. 
Further breakdown of hypoxanthine to uric acid and the salvage passage of 
hypoxanthine to inosine monophosphate are blocked during hypoxia, with 
subsequent accumulation of hypoxanthine in the tissues. 
3.3.2 Free Radical Generation And Fetal Hypoxia-Reoxygenation 
Hypoxic damage to ion transport leads to intracellular entrance of Ca^ "" ions, 
which catalyze the conversion of xanthine dehydrogenase to xanthine oxidase. 
When the accumulated hypoxanthine is degraded to xanthine and uric acid 
catalysed by xanthine oxidase, free radicals are generated. Several animal 
studies have demonstrated increased levels of lipid peroxides, following 
hypoxia-reoxygenation. In an animal model utilizing arterial catheterized in fetal 
lambs, graded hypoxia was established by intermittent total umbilical cord 
compression of 30，60，90 seconds duration, occurring every minute for a total of 
27 occlusions over 81 minutes. The main outcome parameter was the arterio-
venous differences in the concentration of organic hydroperoxides (OHP), 
measured in paired carotid arterial and jugular venous blood, samples as an 
index of oxidative stress in the fetal brain. The result of the study was that the 
peroxidation of lipids in the brain occured under conditions of severe hypoxia 
and reperfusion associated with intermittent umbilical cord occlusions of 60 
seconds or longer. Another experimental study, which involved alterative 
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ligation and releasing of uterine arteries to induce hypoxia-reoxygenation in fetal 
rabbits, demonstrated that repetitive hypoxia-reoxygenation was associated with 
significantly higher levels of lipid peroxides in brain tissue than found after a 
single in once-hypoxia-reoxygenation event or after hypoxia with no 
reoxygenation [133]. These findings support the hypothesis that fetal hypoxia-
reoxygenation is associated with increased free radical production and lipid 
peroxidation in the fetal brain. 
During labour, uterine contractions lead rhythmically to placental vascular or 
cord vessel relaxation and constriction. Repetitive uterine contraction results in 
intermittent hypoxia-reoxygenation, with increased free radical mediated lipid 
peroxidation. Previous studies have provided substantial evidence that is 
associated with high lipid peroxidation in women undergoing vaginal delivery [72， 
134，135]. 
3.3.3 Fetal Hypoxia And Fetal Brain Injury 
Fetal hypoxemia causes blood flow redistribution. Blood flow to the brain, heart, 
and adrenals increases two- to three-fold in these fetuses while the blood flow to 
lung, kidney, spleen and gut decreases [136, 137]. The restoration of blood flow 
is necessary for survival of the vital organs, but it is critical because damage 
may be amplified during this period. Neurological injury is the most serious 
complication among neonatal sequelae of perinatal hypoxia. 
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Recently, more and more evidence suggests that neurological damage is 
associated with free radical-induced oxidative stress. Excessive free radicals are 
generated when reoxygenation following hypoxia. In fetal animal models with 
hypoxia or hypoxia-reoxygenation, it was shown that more serious lipid 
peroxidation within brain tissue occurred in hypoxia-reoxygenation group than in 
those with a single hypoxic event [75, 133]. High level of lipid peroxidation in 
brain tissue with more serious brain edema was discovered in the repetitive 
hypoxia group [133]. The findings support the hypothesis that oxidative injury 
induced by free radicals plays a key role contributing to neurological damage. 
3.3.4 Measurement Of Fetal Hypoxia 
Fetal hypoxia is the main reason contributing to perinatal cerebral palsy. It is 
important to measure the degree of fetal hypoxia, because it may allow early 
diagnosis or provide prognostic significance. Unfortunately, fetal hypoxia cannot 
be readily measured. Only surrogate markers are available, which include acid-
base balance [138], fetal heart rate monitoring [139], Apgar scores, and pulse 
oximetry [140]. 
3.3.4.1 Acid-Base Balance 
As a result of fetal hypoxia, the carbon dioxide concentration in the fetal blood 
rises and respiratory acidosis occurs, resulting in a fall in pH in the fetal 
circulation. In severe hypoxia, the fetal tissues meet their energy requirements 
by anaerobic glycolysis, burning up glycogen but producing lactic acid in the 
process, and this causes further depression of the pH by metabolic acidosis. 
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Acidemia, measured as the concentration of H+ ions, is usually divided into 
respiratory, metabolic, and mixed types. 
The end products of anaerobic metabolism are hydrogen ions (H+) and lactate. 
These metabolites cannot be efficiently cleaned from the fetal circulation through 
the placenta. As a result, there is accumulation of acidic products in the fetal 
circulation. 
Bretscher and Saling (1967) introduced fetal scalp blood sampling for pH 
determination in assessment for fetal distress, which is a complementary to the 
monitoring for fetal heart rate abnormalities [141]. The assessment of the acid-
base status of the umbilical cord arterial blood at birth should have long-term 
prognostic reference. During the last decade, acid-base status in the umbilical 
cord arterial blood was become a routine analysis in many labour wards. 
Although several studies have shown a good correlation between adverse 
neonatal outcome and cord arterial pH less than 7 [69，142-145], the predictive 
value of cord arterial pH >7.0 is much less valuable in predicting neonatal 
outcome [76]. 
3.3.4.2 Fetal Heart Rate Monitoring 
High hydrogen ion concentration subsequent to hypoxia elicites a series of 
clinical signs of fetal distress. The first effect of hypoxia is a rise in fetal heart 
rate from sympathetic stimulation. Fetal tachycardia is the earliest sign of fetal 
hypoxia, indicating cardiovascular compensation in respond to hypoxia. If the 
36 
hypoxia persists and is of a more severe degree, the fetal heart rate will slow 
down after each uterine contraction, Persistent bradycardia occurs in very 
severe cases. 
Continuous fetal heart rate monitoring (CFHR) is widely used to detecting fetal 
distress during labour. However, its routine use is associated with a high false 
positive rate leading to increased operative delivery [146]. CFHR also poorly 
predicts hypoxic damage of the fetus [147]. 
3.3.4.3 Apgar scores 
The Apgar scoring system has become established as the method by which the 
condition of babies is assessed immediately after birth. Manganaro R et al 
discovered that in the term infants 1-mih Apgar score was more influenced by 
the mode of delivery and by gestational age than by asphyxia. Instead, 5-min 
Apgar score had a high concordance with metabolic academia [148]. The 
combination of Apgar scores, metabolic acidemia and arterial desaturation could 
detect neonatal outcome more sensitively [148]. Some investigators, however, 
have shown that the Apgar score by itself is not a totally accurate index of the 
health of the neonate, and that the predictive value of the system is limited [149, 
150]. 
3.3.4.4 Pulse Oximetry 
Within the last ten years, several groups adopted pulse oximetry in the fetus. 
The obvious advantage of this technology is the fact that a biochemical 
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parameter, the arterial oxygen saturation can be measured continuously during 
delivery [151]. The accuracy of pulse oximetry, however, was challenged by 
several studies on its overestimation or lack of sensitivity [152-154]. Besides, it 
is an invasive procedure, which might cause fetal injury and intrauterine infection. 
3.3.4.5 Lipid Peroxides 
Fetal hypoxia initiates excessive free radical, which attacks on phospholipids 
within cell membranes and subsequently produces lipid peroxides. There are 
various types of lipid peroxides. The common types of lipid peroxides used in 
practical study include malondialdehyde (MDA), organic hydroperoxides (OHP) 
and isoprostanes. To compare the three lipid peroxides, the advantages of 
isoprostanes over malondialdehyde and organic hydroperoxides is that its 
production is independent of the cyclooxygenase pathway and therefore the 
surge of prostaglandins related to the labour process will not contribute to its 
elevation. 
Measurement of lipid peroxide levels in biological fluids could directly reflect free 
radical activity and the degree of hypoxia-reperfusion cellular damage [3，155], 
and act as a prognositic indicator for neurodevelopmental handicaps. Many 
previous studies in the obstetric field have reported measurement of lipid 
peroxide levels in maternal blood, fetal blood, amniotic fluid, umbilical cord blood 
and even placental tissues. They may be sensitive and specific for fetal 
condition and for evaluating fetal outcome. The obstetric complications such as 
oligohydramnios [24], tight nuchal cord [79], pregnancy-induced hypertension 
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[156], diabetes mellitus [157-159] and intrauterine growth retardation [129，160], 
which are associated with fetal hypoxia, have been demonstrated to be 
associated with significantly increased lipid peroxide levels in biological fluids 
and placental tissues. Measurement of lipid peroxides in umbilical cord blood is 
a non-invasive technique for detecting the newborn's condition. 
In summary, accurate parameters for detecting perinatal asphyxia early are 
extremely important for assesing neonatal outcome in obstetric practice. 
Currently, umbilical cord blood acid-base status, fetal heart rate monitoring, 
apgar scores or pulse oximetry only reflect fetal metabolic adjustments and 
therefore are not directly related to fetal tissue damage. In contrast, lipid 
peroxides, reflect cellular damage following re-oxygenation of hypoxic tissues [3， 
23]. In this study, isoprostanes will be used to evaluate the relationship between 
meconium stained liquor and fetal hypoxia. In addition the concentration of lipid 
peroxides in cord blood will be used to evaluate the effect of amnioinfusion on 
the pregnancies complicated by moderate or thick meconium stained liquor. 
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CHAPTER 4 AMNIOINFUSION 
4.1 AMNIOINFUSION 
The normal volume of amniotic fluid is essential for normal development of fetal 
organs, and for protection against outside trauma and against cord compression, 
especially during labour. This protection for the fetus is depleted if the volume of 
amniotic fluid is abnormally reduced. In addition, if the amniotic cavity is loaded 
with meconium, it might create a hazardous environment to the fetus, 
predisposing to the development of meconium aspiration syndrome. 
Amnioinfusion, which involves a procedure of infusing normal saline into the 
amniotic cavity, is used as a treatment for pregnancies complicated by 
oligohydramnios or meconium stained liquor. 
4.2 AMNIOINFUSION FOR OLIGOHYDRAMNIOS 
Amnioinfusion was firstly introduced as a technique to infuse medication into 
amniotic cavity for treatment of chorioamnionitis or fetal acidosis [161，162]. In 
1983，Miyazaki et al infused normal saline to expand the volume of amniotic fluid 
in order to relieve variable or prolonged decelerations, thought to be secondary 
to cord compression. In 1987, it was shown by Doppler study that the umbilical 
cord blood flow improved after amnioinfusion was performed for 
oligohydramnios [163]. Amnioinfusion for oligohydramnios was also shown to 
improve fetal condition and neonatal outcome by reducing the incidence of 
operative delivery for fetal distress, the incidence of abnormal fetal heart rate 
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during labour，the incidence of low Apgar score (< 7) at or minutes and the 
incidence of acidosis [164-167]. 
4.3 AMNIOINFUSION FOR MECONIUM STAINED LIQUOR 
After meconium is passed into amniotic fluid, the compounds of meconium might 
be hazardous to the fetus. The risks include meconium-induced inflammation of 
the fetal lung or gestational products [57], placental or cord vasoconstriction [51], 
and meconium aspiration syndrome after birth [168]. Meconium aspiration 
syndrome is associated with a significant increase in neonatal morbidity [52] and 
mortality [169]. Furthermore, it was shown that thick meconium stained liquor is 
usually associated with oligohydramnios [41], an additional risk factor to the 
fetus. 
Infusing normal saline into amniotic cavity for moderate or thick meconium 
stained liquor can directly increase the volume of amniotic fluid and dilute the 
content of meconium in amniotic fluid. A number of previous studies have 
evaluated amnioinfusion for moderate or thick meconium and showed that 
amnioinfusion could effectively decrease the incidence of pathological fetal heart 
rate, caesarean section, meconium aspiration syndrome, low Apgar score and 
low pH value [170-173]. However, the benefit of amnioinfusion for MSL 
pregnancies has been challenged by other studies, which found that there was 
no improvement in the neonatal outcomes [174，175]. To the contrary, 
amnioinfusion may be associated with untoward side effects. Posner et al 
demonstrated a significant increase in uterine tone (p less than 0.05) during and 
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after the infusion together with a higher chance of fetal bradycardia occurring 
[176]. Another study involving 937 pregnancies with moderate or thick 
meconium demonstrated that amnioinfusion significantly increased the 
frequency of pathological CTG，instrumental or operative delivery and 
endometritis [175]. Similarly, Spong et al noted that amnioinfusion did not 
improve neonatal outcome, but increased the risk for chorioamnionitis-
endometritis [177]. As this controversy exists, further evaluation of amnioinfusion 
for moderate or thick meconium stained liquor is required. 
4.4 PURPOSE OF THE STUDY 
It is known that lipid peroxides, the products of lipid peroxidation reflecting 
hypoxic cellular damage by free radicals, are sensitive markers of fetal hypoxia 
during labour [3]_ Intrapartum oligohydramnios was found to be associated with 
raised umbilical arterial blood lipid peroxide levels [24]. Amnioinfusion has been 
shown to reduce cord arterial blood lipid peroxide concentrations in pregnancies 
complicated by oligohydramnios [25]. This finding indicates that amnioinfusion is 
an effective treatment for oligohydramnios, and not only improves clinical 
symptoms but also lower the production of lipid peroxides. The second part of 
this thesis aimed to evaluate whether amnioinfusion in MSL pregnancies could 
lower the level of oxidative stress using 8-iso-prostagladin F2a as the surrogate 
marker. 
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CLINICAL PROTOCOLS 
CHAPTER 5 CLINICAL PROTOCOLS 
5.1 ETHICS 
All women who participated in this study were informed of the nature of the 
study by either the candidate of this thesis or a research assistant and written 
consent forms were obtained. All the materials collected during this research 
were kept confidential and only used for research perposes. 
5.2 CLINICAL PROTOCOLS 
5.2.1 Artificial Rupture Of Membranes (Amniotomy) 
Pregnant women were sent to the delivery suite either after onset of labour was 
diagnosed or if induction of labour was required. Amniotomy was then 
performed if they met the following inclusion criteria: 1) intact amniotic 
membranes; 2) vertex presentation and 3) no cord presentation; and 4) 
favourable cervix (Bishop score 6 or more). The steps of amniotomy consist of a 
vaginal examination to confirm the cervical dilatation, the presenting part and the 
station of presenting part, and the use of an amniotic hook to pierce the amniotic 
membranes. The fingers of the examiner should remain in cervical os to help the 
continuous release of the amniotic fluid in a controlled manner and to detect 
cord prolapse until the flow rate of amniotic fluid had slowed down. The colour of 
the amniotic fluid was recorded at this juncture and also subsequently at each 
vaginal examination. The fetal heart rate was monitored continuously throughout 
the whole intrapartum period. 
43 
5.2.2 Classification of Meconium Stained Liquor 
The colour of the amniotic fluid noted at rupture of membranes and during each 
of the subsequent vaginal examination was recorded on the partogram. The 
degree of MSL, if detected, was further categorised by the attending medical or 
midwifery staff as 1) thin MSL: greenish or yellowish-tinged fluid but without 
particulate matter; 2) moderate MSL: fluid with greenish or yellowish colouring 
with particulate matter; 3) thick MSL: dark green viscous fluid with a 'pea soup' 
characteristics [65, 178]. 
5.2.3 Electronic Fetal Heart Rate Monitoring 
Since fetal distress is very difficult to be defined, for the purpose of this 
study, 'pathological cardiotocography (CTG) tracing' was used as a 
representation of fetal distress. It was defined based on the guidelines published 
by the Royal College of Obstetricians and Gynaecologists on fetal heart rate 
patterns. Definition of categorization of fetal heart rate (FHR) features is shown 
in table 5.1& 5.2. 
5.2.4 Monitoring The Progress of Labour 
It is a department protocol that vaginal examination should be performed every 4 
hours during latent phase of labour and every 2 hours during active phase of 
labour. The examination would be performed more frequently if indicated. 
All relevant findings were recorded on the partogram. These examinations 
include: 1) frequency and intensity of uterine contraction; 2) fetal presentation; 3) 
44 
cervical dilatation; 4) station of the fetal presenting part; 5) the colour of amniotic 
fluid; 6) fetal heart rate; and 7) maternal body temperature and pulse. 
5.2.5 Umbilical Cord Blood Gas Analysis 
As a routine, 1 ml each of arterial and venous whole blood samples was used to 
assay acid-base status within 5 minutes of delivery. It was ensured that there 
was no air bubble trapped within the blood sample in the plastic pre-heparinized 
syringe before it was attached to the analyzer. The brand of machine is Bayer 
and the model is RapidPoint 400. The readings of pH，pC02, p〇2，HC03 and 
BE were obtained from the analyser, which was calibrated daily by the 
laboratory staff. 
5.2.6 Apgar Score 
As a routine, Apgar score was used to assess the condition of a newborn after 
one and five minutes of life. The score assesses five cardinal signs: heart rate, 
respiratory effort, muscle tone, reflexes, and skin colour. Each of the signs is 
scored between 0 and 2. The evaluation of Apgar score for newborns is shown 
in table 5.3. 
A score of 7 to 10 indicates a satisfactory condition, a score of 4 to 7 signifies a 
need for careful observation, and a score of less than 4 implies the need for 
possible emergency procedures and raises doubt about survival. The Apgar 
score at the minutes has greater prognostic significance compared to that at 
theist minute. 
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5.2.7 Meconium Aspiration 
For pregnancies complicated by meconium stained liquor during labour or at 
birth, the delivery was attended by a paediatrian and the babies were assessed 
immediately by paediatricians at birth using direct pharyngoscopy. Meconium 
aspiration was defined as meconium seen below the vocal cords. 
5.2.8 Clinical Outcome 
All information concerning the clinical outcome, including the duration of first and 
second stage of labour, the mode of delivery, complications encountered during 
intrapartum period or delivery, birth weight, Apgar score, umbilical arterial pH 
and the postnatal course were recorded in the partogram, the paediatricians' 
assessment form and the hospital case notes. These case notes were traced 
and reviewed by the candidate of this thesis for the required information. Other 
neonatal information such as congenital malformation or outcome of neonates 
after admission to neonatal intensive care unit was also obtained from the 
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MEASUREMENT OF ISOPROSTANES 
CHAPTER 6 MEASUREMENT OF ISOPROSTANES 
6.1 BLOOD PREPARATION 
Cord blood 5 ml was drawn from the umbilical artery by plastic syringes and put 
into EDTA tube. Blood samples were immediately centrifuged at 1000g for 10 
minutes. Plasma was then collected and stored at -80。C prior to assay for 
isoprostanes. 
6.2 REAGENTS 
The reagents involved in the procedure of 8-iso-PG F2a analysis, including 8-iso-
PGF2a-D4, 8-iso-PGF2a, and other prostaglandin metabolites were obtained 
from Cayman (Ann Arbor, Ml). Bis (trimethylsily) trifluoracetamide (BSTFA), 
pentafluorobenzyl bromide (PFBBr), N, N-diisoproylethylamine (N, N-EA), and 
dodecane were purchased from Sigma (St.Louris, MO). Butylated 
hydroxytoluene (BHT) was from Calbiochem (Milwaukee, Ml). Acetonitrile 
(HPLC grade) was obtained from BDH (Poole, England). Absolute ethanol, 
potassium hydrochloric acid (33%), citric acid, cyclohexane, and ammonia (25%) 
at their highest purity grade were obtained from RDH (Seeize, Germany). 
Octadecyl silica (〇DS) 500mg cartridge (Discovery DSC-18 LT) were from 
Supeico (Bellefonte, PA). Water was purified by a Milli-Q purification system 
from Millipore (Molsheim, France). 
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6.3 GAS CHROMATOGRAPHY AND MASS SPECTROMETRY (GC-MS) 
F2-isoprostanes were chromatographed with a 30m (0.25|jm DB-5MS capillary 
column on an Agilent 7683 autosampler and interfaced to an Agilent 5973N 
mass spectrometer in negative chemical ionization mode (Agilent, CA). The 
reagent gas used was methane at a flow rate of 2ml/min, and the carrier gas 
was helium at a flow rate of Iml/min. Data were acquired and analyzed by an 
Enhance Chemstation, version C.00.00. Injection mode was splitless with inlet 
temperature 280°C and an injection volume of 1|JI. The GC oven temperature 
program was initially set at 150。C for 4 min, increased to 190。C at 10。C /min 
and then to 310。C at 20。C/min，and maintained at this temperature for 15 min. 
The transfer line temperature was kept at 310°C. Ion source temperature and 
quadrupole temperature were both set at 150。C. Selected ion monitoring mode 
was used to detect F2-isoprostanes and PGF2a-D4 at 569 and 573 amu, 
respectively. Electronic multiplier offset was 400mV. The dwell time was 70 ms 
for each mass. 
6.4 PROCEDURES 
Cord blood 8-iso-PG fza was purified and measured in this study according to a 
modified and validated method as previously described [78], 
Deproteinization: 1ml of cord blood plasma mixed with 20pg internal standard 8-
iso-PG2oD4 and PGF2a-D4 and 2ml 100% ethanol containing 0.005% BHT and 
0.025% tripheny丨phosphine and then centrifuged at 3000 g at 4。C for 10 min. 
Base hydrolysis: The supernatant was collected and mixed with 2ml 15% 
potassium hydroxide at 40°C for 1 hour. The mixture was then adjusted to pH 3-
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4 with HCI, then mixed with 1.0 ml 0.02M citric acid and purged with nitrogen to 
remove the organic solvent about 2ml. 
Purification: The sample mixtures were then applied to 〇DS cartridges, which 
had been pre-conditioned with 2 ml acetonitrile, 2ml MilliO water, and 2ml 0.02M 
citric acid, and the columns were washed by 1ml 0.02M citric acid, 2ml 10% v/v 
methanol, and 3ml cyclohexane. Sample molecules were eluted with 3ml 25% 
ammonia solution/ 100% methanol mixture (3/97). The cartridges were not dried 
except in the final elution step. Collected the eluent samples by 3ml ice-cold 3% 
NHa- H2O in methanol was dried under nitrogen to about 0.5ml and then was 
transferred to an eppendorf tube and centrifuged at 13,000g for 5 min. The 
supernatant was collected into new tube and evaporated to complete dryness 
under nitrogen. 
Derivatization: The residue was mixed with 40|jl 10% PFBBr in acetonitrile and 
20|jl 10% N, N-EA and incubated at room temperature for 30 minutes. The 
procedure was repeated one more time. 20 fjl BSTFA and lOpI acetonitrile 
mixture were added to the residue and incubated at 45。C for 20 minute. The 
mixture was again evaporated to dryness by nitrogen purge. Finally the residue 
was dissolved in 20[jl dodecane by sonication and vortexing for 30 seconds. 
After centrifugation at 13’000g for 2 min, the supernatant was analyzed by GC-
MS. 
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6.5 DATA RELIABILITY 
The absolute recovery of 8-iso PGF2a was 65±5.1o/o (Mean土SD: 95% 
confidences). Intra-day precision (n=7) and inter-day precision (n=4), recovery 
standard deviation (RSD), were about 10%. Accuracy was 97.4±1.9 %) 
(Mean土SD: 95% confidences). Linearity, P, over the range of 10-5000 pg/ml in 
plasma was 0.9985. Method detection limit (MDL) was 21 pg/ml (99% 
confidences). 
Calculation of 8-iso-PGF2a concentrations in blood samples: 
1. Linearity was established by determining the responses ratio of 8-iso-
PGF2a and PGF2a-d4 in standard calibration solutions (PGFpa-cU and 8-
iso-PGF2a： 0.625, 1.25，2.5, 5, and 10 pg/ml). Linear regressions and the 
regression coefficient were then calculated. 
2. The regression coefficient (i^ in different batch was 0.998) in average was 
about the equations y=0.0664x + 0.0196 for 8-iso-PGF2a calculation. 
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MECONIUM STAINED LIQUOR (MSL) DURING LABOUR 
ASSOCIATED WITH RAISED NEONATAL CORD BLOOD 8-ISO-
PROSTAGLANDIN F2a CONCENTRATION 
CHAPTER 7 MECONIUM STAINED LIQUOR (MSL) DURING 
LABOUR AND NEONATAL CORD BLOOD S-ISO-PGFza 
CONCENTRATION 
7.1 OBJECTIVE 
As discussed in previous chapters, meconium stained liquor (MSL) is a common 
finding during labour. Reported incidence varied between 7-22% [1]. In a review 
of 9,542 singleton pregnancies in Hong Kong, the incidence of MSL increased 
progressively from 6% in preterm gestation to 29.5% at 41 weeks of gestation 
[31]. Association of moderate or thick MSL and other adverse pregnancy 
outcomes including low Apgar scores at birth, fetal acidemia and hypoxaemia, 
emergency caesarean section or instrumental delivery for fetal distress, 
meconium aspiration syndrome and neurodevelopmental handicaps have also 
been reported by other studies [41，55, 63，65, 179-181]. However, despite all 
these findings, most pregnancies with moderate or thick MSL have good 
neonatal outcomes [1]. Thus, the relation between meconium stained liquor and 
fetal hypoxia is still inconclusive. 
Recent work has shown that the products of free radical-mediated lipid 
peroxidation, which are surrogate markers of oxidative stress, are elevated in 
the fetal circulation in response to intrapartum hypoxia [3]. Their measurement in 
umbilical cord arterial blood has been proposed to be an additional marker of 
fetal hypoxia. The objective of the first part of this thesis was to compare the 
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umbilical arterial 8-iso-PGF2a, concentrations between pregnancies complicated 
by meconium stained liquor and those with clear liquor. 
7.2 MATERIALS AND METHOD 
This was a prospective observational study conducted in the delivery suite of the 
Prince of Wales Hospital in Hong Kong. Women were invited to participate in 
this study if they met the following inclusion criteria: 1) singleton pregnancy; 2) 
gestational age between 37-42 weeks; 3) no known fetal malformation; 4) no 
maternal diseases and 5) no obstetric complications such as intrauterine growth 
retardation. Subjects were excluded if 1) intrapartum amnioinfusion has been 
performed, or 2) fetal malformation was detected after birth. The gestational age 
was determined either by the menstrual date or by early ultrasound scan if there 
was a discreparcy between uterine size and calculated gestation. All obstetric 
management and intervention was determined by the attending midwifery and 
medical staff, who were not involved in this study. Intrapartum management was 
governed by an internally published protocol, which all staff were required to 
follow. The colour of the amniotic fluid noted at rupture of membranes and 
during each of the subsequent vaginal examination was recorded on the 
partogram. The degree of MSL, if detected, was categorised by the attending 
medical or midwifery staff into thin, moderate, thick MSL based on criteria stated 
in Chapter 5. Clinical protocols, the criteria of neonatal outcome and laboratory 
assay method have also been shown in chapter 5. The laboratory staff 
responsible for the assay was blinded from the obstetric outcomes at the time of 
the assay. 
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Only women with moderate or thick MSL detected at any time during labour or at 
delivery were included in the MSL group. None of these subjects received 
amnioinfusion. The control group consisted of those subjects with clear amniotic 
fluid at all stages of labour. Women with thin MSL at all stages of labour were 
not included for analysis. The study groups are: 
MSL group: All subjects with moderate or thick meconium stained liquor at any 
stage of labour or at delivery and did not receive amnioinfusion; 
Control group: All subjects with clear amniotic fluid at any time of labour or at 
delivery. 
7.3 STATISTICAL ANALYSIS 
All statistical analyses were performed using SPSS 11.1 (SPSS Inc, Illinois, 
USA). The clinical characteristics between MSL and control groups were 
compared using Mann Whitney U, student t-test or X^ tests, whichever was 
appropriate. Correlation between the umbilical arterial 8-iso-PGF2a 
concentrations and fetal outcome variables was assessed using Spearman's 
correlation. The umbilical arterial 8-iso-PGF2a concentrations between MSL and 
control groups were compared using the Mann Whitney U test. Multiple 
regression analysis was used to identify the independent determinants of 
umbilical arterial 8-iso-PGF2a concentrations. A value of p < 0.05 was 
considered statistically significant. 
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Sample size of the study was calculated as follows: at a type 1 error of 0.05 and 
a power of 80%, the sample size required to detect a mean difference of 8-iso-
PGF2a concentrations equivalent to 0.5 times of the standard deviation is 42，if 
the ratio of the control to index subjects was 3:1. 
7.4 RESULTS 
There were 192 pregnancies in control group and 55 pregnancies in the MSL 
group. 
The clinical parameters of the moderate or thick MSL and control groups are 
shown in table 7.1. The MSL group was significantly higher in gestational age at 
delivery and had longer duration of first stage of labour，higher incidence of 
'pathological CTG tracing' and higher frequency of emergency caesarean 
section compared to the control group. Regarding the neonatal outcomes, the 
MSL group had a significantly higher proportion of requiring admission to 
neonatal intensive care unit. There was no difference in the 5-minute Apgar 
score or umbilical cord arterial PH at delivery. Four infants in the MSL group had 
meconium detected below the vocal cord after delivery (Table 7.2). 
The median 8-iso-PGF2a concentrations in the umbilical arteries of the MSL and 
control groups were 719.2pg/ml (interquartile range IQR: 448.1-935.0 pg/ml) and 
115.8 pg/ml (IQR: 86.4-164.0) respectively (Figure 7.1). The difference was 
statistically significant (p<0.001). 
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To avoid the confounding effect of fetal heart rate abnormalities, which might be 
a confounding factor for the level of lipid peroxides, analysis was repeated with 
inclusion of those pregnancies with normal intrapartum CTG tracing only (i.e., no 
clinical evidence of fetal distress). There were 166 subjects in control group and 
37 cases in the MSL group. The median of 8-iso-PGF2a concentrations 
remained significantly higher in the MSL group [721.5 pg/ml (IQR: 506.7-916.0) 
versus 112.4pg/ml (IQR: 85.5-159.0), (p<0.001)] (Figure 7.2). 
Analysis was also repeated with limiting women in their first labour only. There 
were 90 subjects in the control group and 34 subjects in the MSL group. There 
was no significant difference in the first and second stages of labour between 
groups. The median of 8-iso-PGF2a concentrations in umbilical arteries 
remained significantly higher in the MSL group comparing to that in the control 
group [641.2 pg/ml (IQR: 401.8-889.2) versus 138.5 pg/ml (IQR: 101.9-199.7)]. 
Correlations between cord arterial 8-iso-PGF2a concentrations and other 
variables including duration of second stage of labour, Apgar scores, umbilical 
arterial pH were assessed. Only the duration of second stage of labour 
significantly correlated to cord arterial 8-iso-PGF2a concentrations (Correlation 
Coefficient=0.185, p=0.006). There was no correlation between umbilical arterial 
8-iso-PGF2a concentrations and other fetal outcome variables. 
As there were significant differences in clinical parameters between the MSL 
and control groups (Table 7.1), multiple regression analysis was performed to 
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check if MSL was an independent determinant of umbilical arterial 8-iso-PGF2a 
concentrations. Stepwise logistic regression was used with cord arterial 8-iso-
PGF2C7 concentrations as the dependent variable. Variables assessed included 
gestational age, duration of first stage of labour, mode of delivery, presence of 
pathological CTG tracing as there was significant difference in these variables 
between the MSL and control groups. Although there was no difference in the 
duration of second stage of labour between the MSL and control groups, this 
variable was added into the regression analysis because it was correlated with 
the cord arterial 8-iso-PGF2a concentrations. 
Using multiple regression analysis, moderate or thick MSL (p < 0.001)，duration 
of second stage of labour (p = 0.008) and pathological CTG tracings (p = 0.017) 
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Control MSL 
(n=192) (n=55) 
Figure 7.1 Comparison of umbilical cord arterial concentration of 8-iso-PGF2a 
in pregnancies complicated by moderate or thick meconium stained liquor (MSL 
group) and normal pregnancies with clear liquor (Control group). The box 
represents the median and interquartile ranges. The ‘〇，and the ‘X’ represents 
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Control with Control with MSL with MSL with 
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(n=166) (n=26) (n=37) (n=18) 
Figure 7.2 Comparison of umbilical cord arterial concentration of 8-iso-PGF2a 
in pregnancies complicated by moderate or thick meconium stained liquor (MSL 
group) and normal pregnancies with clear liquor (Control group) with normal or 
abnormal CTG The box represents the median and interquartile ranges. The "O" 
and the "X" represents the outlines and extremes respectively. 
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7.5 DISCUSSION 
The findings indicated that moderate or thick MSL is associated with elevated 
total 8-iso-PGF2a concentrations in the umbilical artery. In particular, the 
association was independent of abnormal intrapartum CTG tracings and 
increased duration of second stage of labour, which are the other intrapartum 
risk factors for elevated isoprostane levels. Total 8-iso-PGF2a is a specific 
marker of oxidative stress, which is a process initiated by intracellular hypoxia. 
Therefore, the current findings are in line with the belief that moderate or thick 
MSL is a sign of fetal hypoxic response. 
Raised concentrations of other products of oxidative stress including 
hypoxanthine, xanthine or uridine have been found in extra cellular fluid such as 
meconium stained amniotic fluid (mainly comprised of fetal urine) [182] or in 
newborn plasma [183] under fetal hypoxic condition. It is known that intracellular 
hypoxia leads to depletion of the energy rich compound ATP and increase in its 
degradation products. Depletion of ATP, in turn, leads to intracellular entrance of 
calcium ions [184]., increased entrance of calcium ions can convert xanthine 
dehydrogenase to xanthine oxidase, and under the reperfusion phase，the 
purine metabolites hypoxanthine and xanthine are metabolized, free radicals are 
generated [185, 186]. These free radicals trigger the chain reaction of 
peroxidation of phospholipids in the cell membrane, as well as the damage on 
proteins and nucleic acids. A series of pathophysiological changes may result in 
cellular injury and subsequently even cell death. Comparing to hypoxanthine, 
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which is the breakdown product of energy rich nucleotides, isoprostanes are 
products of lipid peroxidation within cell membrane and are a more specific 
marker for reflecting oxidative stress induced cellular injury. It has been 
demonstrated in clinical study that isoprostanes are more sensitive indicator of 
fetal outcome than the traditional parameters such as acid-base values or other 
oxidative stress products (OHP) [79]. In addition, the relation between 
intermittent acute hypoxia and raised lipid peroxidation was supported in a 
previous animal models [75, 133] and in clinical study [3，79]. Elevation of 8-iso-
PGF2a in cord arterial blood in pregnancies complicated by moderate or thick 
MSL suggests that MSL is a sign of fetal hypoxic response. 
In the past, MSL was not considered as an independent risk factor for fetal 
distress unless there was concomittent presence of pathological fetal heart rate 
patterns [187]. However, the current data demonstrated that the concentration of 
isoprostanes remained high in MSL group despite normal CTG tracings. The 
result suggests that MSL pregnancies are associated with a high degree of 
oxidative stress and that some degree of fetal hypoxia exists even without 
clinical changes in the CTG. 
Using multiple regression analysis, the duration of second stage of labour and 
abnormal fetal heart tracings were identified as two other independent 
determinants of umbilical arterial 8-iso-PGF2a concentration. These were in 
support of our early findings using other products of lipid peroxidation, 
malondialdehyde (MDA) and organic hydroperoxides (OHP), which were also 
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elevated in prolonged second stage of labour [135] and in asphyxiated fetuses 
[3]. One of the advantages of 8-iso-PGF2a over malondialdehyde and organic 
hydroperoxides is that its production is independent of the cyclooxygenase 
pathway and therefore the surge of prostaglandins related to the labour process 
will not contribute to its elevation. 
Although it is established that oxidative stress can damage many biological 
molecules [188] and its occurrence in the perinatal period might play a role in 
neonatal damage [189], the extent and significance of this damage in each 
individual baby still cannot be estimated from the currently available data. The 
clinical outcomes of the study cohort were apparently good, based on the 
conventional measures such as Apgar scores, cord arterial pH and base deficit. 
Although these conventional outcomes are not sensitive markers for 
neurological handicap, most of the infants are unlikely to have severe adverse 
outcomes. Should this increased level of oxidative stress or underlying 
intermittent hypoxia in the MSL group be regarded as a sub-clinical event? 
Further research should be directed towards the level of lipid peroxides, which is 
critical for adverse neonatal outcomes. 
7.6 CONCLUSION 
To conclude, moderate or thick MSL is an independent determinant of elevated 
umbilical arterial 8-iso-PGF2a concentration. This finding indicates that moderate 
or thick meconium stained liquor is a pathological event associated with higher 
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degree of fetal oxidative stress which might be triggered by intracellular hypoxia 
resulting in lipid peroxidation and other cellular damage by free radicals. 
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CHAPTER 8 EVALUATION OF PROPHYLACTIC 
AMNIOINFUSION FOR INTRAPARTUM MECONIUM STAINED 
LIQUOR 
8.1 OBJECTIVE 
Heavy MSL is associated with increased risk of adverse neonatal outcome. 
There is some evidence to suggest that prophylactic amnioinfusion is an 
effective intervention for MSL to prevent variable deceleration or bradycardia, 
caesarean section for fetal distress, low Apgar score and meconium aspiration 
during labour. We have demonstrated that moderate or thick MSL is associated 
with a greater extent of lipid peroxidation and cellular damage by free radicals. 
The objective of this study is to evaluate the effect of prophylactic amnioinfusion 
on preventing lipid peroxidation for intrapartum moderate or thick MSL. 
8.2 MATERIALS AND METHOD 
8.2.1 Study Group: ‘ MSL+AI， 
This was a case controlled study conducted in the delivery suite of The Chinese 
University Hong Kong. A cohort of 30 subjects with moderate or thick MSL 
during labour was recruited and received amnioinfusion. The procedure of 
amnioinfusion is described in section 8.2.2. This formed the 'MSL+AI' group. 
Other inclusion criteria included: 1) singleton pregnancy; 2) gestational age 
between 37-42 weeks; 3) no known fetal malformation; 4) no maternal diseases 
and 5) no obstetric complications such as intrauterine growth retardation. The 
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gestational age was determined either by the menstrual date or by early 
ultrasound scan if there was a discreparcy between uterine size and calculated 
gestation. All other obstetric management and intervention was determined by 
the attending midwifery and medical staff, who were not involved in this study. 
Intrapartum management was governed by an internally published protocol, 
which all staff were required to follow. Upon delivery, umbilical cord arterial 
blood was collected and assayed for total 8-iso-PGF2a concentration as 
described in Chapter 6. 
8.2.2 The Procedure Of Amnioinfusion 
The amniotic membranes should have been ruptured either spontaneously or by 
amniotomy prior to the amnioinfusion. Vaginal examination was performed to 
rule out cord prolapse, and to assess cervical dilatation and fetal presentation. A 
scalp electrode and an indwelling intrauterine pressure catheter were placed into 
the amniotic cavity via the transcervical route. One litre normal saline solution 
was infused into amniotic cavity by gravity through the indwelling intrauterine 
pressure catheter. Infusions were given over approximately 30 minutes, and 
repeated after 4 hours if the patient remained undelivered. Amnioinfusion would 
be stopped when completed or on reaching the second stage of labour or if 
labour was terminated earlier by caesarean section. Saline solutions were 
stored at room temperature on the delivery suite and were not warmed prior to 
infusion. 
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8.2.3 Other Study Group 
The clinical data and results of the umbilical cord arterial total 8-iso-PGF2a 
concentrations of the ‘MSL+AI’ group were compared with the two cohorts 
recruited in chapter 7 namely: 
MSL-AI group: The pregnancies with moderate or thick meconium stained liquor 
at any time of labour or at delivery but which did not receive amnioinfusion; 
and 'Clear liquor' group: The pregnancies with clear amniotic fluid at any time 
during labour and at delivery. 
When comparing the 'MSL+AI' and 'MSL-AI' groups, the sample size of 30 
subjects in the ‘MSL+AI’ group allowed detection of a mean difference 
equivalent to 0.75 times of the standard deviation, at a type 1 error of 0.05 and a 
power of 80%. 
8.3 STATISTIC ANALYSIS 
All statistical analyses were performed using SPSS 11.1 (SPSS Inc, Illinois, 
USA). The clinical characteristics between the 'MSL+AI' and 'MSL-AI' groups 
and between the 'MSL+AI' and the 'clear liquor' groups were compared using 
Student's t-test, Mann Whitney U or X^ tests, whichever was appropriate. The 
umbilical arterial 8-iso-PGF2a concentrations between 'MSL+AI' group and 'MSL-
AI' groups and between the 'MSL+AI' and 'clear liquor' groups were compared 




Of the 30 pregnancies in the 'MSL+AI' group, one was subsequently excluded 
due to maternal gestational diabetes，which was only discovered at review of 
case notes. As a result, there were only 29 subjects in the 'MSL+AI' group. Fifty-
five pregnancies in the 'MSL-AI' group and 192 pregnancies in the 'clear liquor' 
group were used for comparison. The clinical characteristics of the 3 groups and 
their comparison are shown in Table 8.1. The neonatal outcomes are shown in 
Table 8.2. 
8.4.1 Comparison Between The ‘MSL+AI，And 'MSL-AI' Groups 
There were no significant differences in maternal age, gestational age, and 
duration of first or second stage of labour and birth weight between the two 
groups (Table 8.1). There were also no significant differences in incidence of 
abnormal CTG tracings, caesarean section or instrumental delivery, meconium 
aspiration, low Apgar score at first or fifth minutes, umbilical cord arterial pH and 
base deficit between two groups (Table 8.2). The median umbilical cord arterial 
8-iso-PGF2a concentration of the 'MSL+AI' group was 143.4 pg/ml (IQR: 95.5-
370.4), which was significantly lower than that of the 'MSL-AI' group [719.2 









































































































































































































































































































































































































































































































8.4.2 Comparison Between ‘MSL+AI，And ‘Clear Liquor' Groups 
There was a small but significant difference in the gestational age between the 
two groups (40.1 ±0.8 vs. 39.6 ±1.2, p<0.05). Duration of first stage was longer in 
MSL+AI group than that in clear liquor group [379 minutes (IQR: 240-642) v.s. 
282 minutes (195-428), p <0.05]. The incidence of cesaerean section was 
higher in MSL+AI group than that in clear liquor group but there was no 
significant diffierence in the incidence of fetal distress between groups (Table 
8.1 & 8.2). There was no significant difference in the umbilical cord arterial 8-iso-
PGF2a concentrations between the 2 groups [143.4(IQR: 95.5-370.4) vs. 
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Clear liquor MSL+AI MSL-AI 
(n=192) (n=29) (n=55) 
Figure 8.1 Comparison of cord arterial 8-iso-PGF2a concentration in 
pregnancies in clear liquor group, MSL+ Al group, and MSL- Al group [MSL+AI 
vs. MSL-AI (p<0.001); MSL+AI vs. clear liquor (p>0.05)]. The box represents the 




This is a cohort study with selected controls showed that the MSL pregnancies 
that received amnioinfusion ('MSL+AI' group) were associated with a 
significantly less degree of lipid peroxidation compared to MSL pregnancies that 
received no amnioinfusion ('MSL-AI' group). Furthermore, there was no 
difference in the extent of lipid peroxidation between the 'MSL+AI' and the 'clear 
liquor' groups. The current data indicate that amnioinfusion is a beneficial 
intervention not only for oligohydramnios, but also for moderate or thick MSL 
pregnancies to effectively alleviate lipid peroxidation and cellular damage by free 
radicals. 
It has been suggested that meconium stained liquor might present a hazardous 
environment for the fetus as it may induce inflammation in placental or umbilical 
cord tissue [50] or cause vasoconstriction of the placenta [51], which can be 
associated with ischemic, hypoxemic cerebral palsy [55]. Also, it has been 
shown that this meconium-induced vasoconstriction is a concentration 
dependent [54], meaning that a lower concentration of meconium in the amniotic 
fluid is associated with lesser effect of vasoconstriction on placental or umbilical 
cord vasculature. Infusing normal saline into the amniotic cavity directly dilutes 
the concentration of meconium in amniotic fluid and may subsequently alleviate 
the vasoconstrictive effects of meconium on the placenta or fetal vessels. A 
lesser degree of vasoconstriction means an increase of blood supply from the 
placenta to the fetus, and this could essentially improve any fetal hypoxic 
condition. This might lead to less production of 8-iso-PGF2a-
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Intrauterine meconium aspiration can also lead to lung damage [56, 57, 190], 
which may contribute to the increased neonatal morbidity and mortality observed 
in infants with meconium aspiratory syndrome [1]. In an autopsy findings 
reported that meconium may stimulate actual intrauterine pneumonitis 
contributing to stillbirth [190]. The intrauterine pneumonitis may associate with 
vasoconstriction and increased oxidative stress. Amnioinfusion rapidly dilutes 
the concentration of the meconium, thereby reducing the amount of meconium 
aspirated into the lung and subsequently reducing meconium induced chemical 
injury in fetal lung. 
At the same time, increasing the amniotic fluid volume by amnioinfusion can 
help to relieve cord compression during labour, which might be one of the 
inducers of fetal hypoxia. This hypothesis is supported by a previous study that 
amnioinfusion was associated with a lower incidence of fetal variable 
deceleration or bradycardia [171]. 
However, the results need to be interpreted with caution because this study was 
not without its limitations. It was not a randomised trial and was subjected to 
potential bias, including case selection for amnioinfusion, possibly different 
background characteristics among the study cohorts, and different underlying 
reasons for MSL However, there were no significant differences in the maternal 
variables and the duration of labour between the 'MSL+AI' and 'MSL-AI' groups. 
The observation should lay the foundation for further randomised controlled 
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study on evaluating the efficacy of amnioinfusion, with particular attention to the 
effect on oxidative stress. 
8.6 CONCLUSION 
In summary, in this cohorn study with selected control, amnioinfusion is 
associated with lower umbilical cord arterial total 8-iso-PGF2a concentration in 
pregnancies with moderate/ thick MSL. Amnioinfusion appeared to reduce the 
extent of oxidative stress in moderate/ thick MSL pregnancies to a similar level 
to that in normal pregnancies with clear liquor. 
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CHAPTER 9 COMMENTS AND FUTURE RESEARCH 
Meconium stained liquor is a common finding during labour in certain 
populations. In this thesis, it was examined firstly if MSL pregnancies were 
associated with a high level of oxidative stress in the fetus, and secondly 
whether the procedure of amnioinfusion could lower the level of oxidative stress. 
8-iso-PGF2a, one of the products of lipid peroxidation specific to oxidative stress 
was chosen as the surrogate marker for oxidative stress. 
The results revealed increased umbilical arterial 8-iso-PGF2a concentration in 
pregnancies complicated by moderate/ thick MSL compared to those with clear 
liquor. Meconium stained liquor, duration of second stage of labour，and 
abnormal fetal heart tracings were found to be independent determinants of cord 
blood 8-iso-PGF2a concentration. Amnioinfusion was associated with lower 
umbilical cord arterial total 8-iso-PGF2a concentration in pregnancies with 
moderate/thick MSL. The umbilical cord arterial total 8-iso-PGF2a concentrations 
in the amnioinfusion group were not significantly different from the normal 
pregnancies with clear liquor. 
A causal model between intermittent acute hypoxia-reperfusion and the 
production of lipid peroxides has been demonstrated previously in animal 
models [23]. The present findings are in line with the belief that moderate or 
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thick MSL is a sign of fetal hypoxic response. Amnioinfusion appears to alleviate 
the oxidative stress associated with moderate/thick MSL. 
One of the limitations of the current findings is that the measurement of the 
umbilical cord blood isoprostanes after birth only reflects the condition of the 
newborn instead of the fetal condition at the time of meconium passage. The 
data of this thesis are unable to answer whether MSL is the result or the cause 
of oxidative stress. Amniotic fluid, which is mainly composed of fetal urine，could 
be an excellent source reflecting the alteration of fetal metabolic condition. 
Measurement of the lipid peroxide levels in the amniotic fluid as soon as MSL is 
discovered may provide a better assessment of the fetal state at the time of 
meconium passage. 
The timing of meconium discovered in the amniotic fluid and its significance may 
also be of value to study. It has been suggested that the late meconium passage 
during labour in women with clear fluid at the time of amniotomy is more likely to 
be associated with birth asphyxia compared to those with meconium at the time 
of membrane rupture [67]. Meis et al have previously addressed the issue of late 
passage of meconium in labour and concluded that neither late MSL or 
abnormal CTG tracings alone was predictive of neonatal morbidity but the 
combination of both was, and could be a sensitive predictor for the risk of fetal 
asphyxia if it is in combination with other intrapartum signs [191]. If some MSL 
pregnancies are the result of a physiological phenomenon，it might be that the 
proportion was less with the late MSL group, which passes meconium as a 
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result of stress related to the labour. The timing effect of meconium appearing in 
amniotic fluid should be considered in the future study. 
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